These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Impairment of renal function in Schnitzler's syndrome. Westhoff TH; Zidek W; Uharek L; Steinhoff-Georgieva J; van der Giet M J Nephrol; 2006; 19(5):660-3. PubMed ID: 17136697 [TBL] [Abstract][Full Text] [Related]
5. Beneficial response to anakinra and thalidomide in Schnitzler's syndrome. de Koning HD; Bodar EJ; Simon A; van der Hilst JC; Netea MG; van der Meer JW Ann Rheum Dis; 2006 Apr; 65(4):542-4. PubMed ID: 16096327 [TBL] [Abstract][Full Text] [Related]
11. Malignant evolution of Schnitzler's syndrome--chronic urticaria and IgM monoclonal gammopathy: report of a new case and review of the literature. Lim W; Shumak KH; Reis M; Perez-Ordonez B; Sauder D; Fam A; Imrie KR Leuk Lymphoma; 2002 Jan; 43(1):181-6. PubMed ID: 11908725 [TBL] [Abstract][Full Text] [Related]
12. Schnitzler's syndrome: diagnosis, treatment, and follow-up. Simon A; Asli B; Braun-Falco M; De Koning H; Fermand JP; Grattan C; Krause K; Lachmann H; Lenormand C; Martinez-Taboada V; Maurer M; Peters M; Rizzi R; Rongioletti F; Ruzicka T; Schnitzler L; Schubert B; Sibilia J; Lipsker D Allergy; 2013; 68(5):562-8. PubMed ID: 23480774 [TBL] [Abstract][Full Text] [Related]
13. Schnitzler's syndrome with monoclonal IgG kappa gammopathy: good response to cyclosporin. Pascual-López M; Hernández-Núñez A; Sánchez-Pérez J; Fernández-Herrera J; García-Díez A J Eur Acad Dermatol Venereol; 2002 May; 16(3):267-70. PubMed ID: 12195569 [TBL] [Abstract][Full Text] [Related]
14. [A woman with recurrent urticaria, joint pain and fever]. Gran JT; Midtvedt Ø; Haug S Tidsskr Nor Laegeforen; 2011 Jan; 131(2):135-6. PubMed ID: 21267032 [TBL] [Abstract][Full Text] [Related]
16. Skin and Systemic Inflammation in Schnitzler's Syndrome Are Associated With Neutrophil Extracellular Trap Formation. Bonnekoh H; Scheffel J; Wu J; Hoffmann S; Maurer M; Krause K Front Immunol; 2019; 10():546. PubMed ID: 30967871 [TBL] [Abstract][Full Text] [Related]
17. Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome. de Koning HD; Schalkwijk J; van der Ven-Jongekrijg J; Stoffels M; van der Meer JW; Simon A Ann Rheum Dis; 2013 Oct; 72(10):1634-8. PubMed ID: 23087179 [TBL] [Abstract][Full Text] [Related]
19. Successful treatment of Schnitzler's syndrome with anakinra after failure of rituximab trial. Cascavilla N; Bisceglia M; D'Arena G Int J Immunopathol Pharmacol; 2010; 23(2):633-6. PubMed ID: 20646359 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of interleukin-1 blockade in Schnitzler's syndrome without detectable monoclonal gammopathy: a case-based review. Bixio R; Rossini M; Giollo A Clin Rheumatol; 2021 Jul; 40(7):2973-2977. PubMed ID: 33175311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]